• Published On : Aug-2017 |
  • Pages : 256 Pages |
  • Format :

Table of Content

1. Executive Summary
   1.1. Market Overview
   1.2. Market Analysis
   1.3. PMR Analysis and Recommendations
   1.4. Wheel of Fortune

2. Market Introduction
   2.1. Market Definition
   2.2. Market Taxonomy

3. Orally Disintegrating Tablets Market Opportunity Analysis 
   3.1. Macro-Economic Factors
   3.2. Opportunity Analysis
   3.3. Value Chain

4. North America Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025
   4.1. Introduction
   4.2. Regional Market Dynamics
        4.2.1. Drivers
        4.2.2. Restraints
        4.2.3. Trends
   4.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        4.3.1. U.S.
        4.3.2. Canada
   4.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        4.4.1. U.S.
        4.4.2. Canada
   4.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        4.5.1. Anti-Psychotic
        4.5.2. Anti-Epileptic’s
        4.5.3. CNS Stimulants
        4.5.4. Anxiolytics
        4.5.5. Anti-Parkinson Ian Drugs
        4.5.6. Anti-Hypertensive
        4.5.7. NSAIDS
        4.5.8. Anti-Allergy Drugs
        4.5.9. Proton Pump Inhibitor
        4.5.10. Others
   4.6. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        4.6.1. Anti-Psychotic
        4.6.2. Anti-Epileptic’s
        4.6.3. CNS Stimulants
        4.6.4. Anxiolytics
        4.6.5. Anti-Parkinson Ian Drugs
        4.6.6. Anti-Hypertensive
        4.6.7. NSAIDS
        4.6.8. Anti-Allergy Drugs
        4.6.9. Proton Pump Inhibitor
        4.6.10. Others
   4.7. Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016
        4.7.1. Central Nervous System Diseases (CNS)
        4.7.2. Gastrointestinal (GI) Diseases
        4.7.3. Cardiovascular(CVS) Diseases
        4.7.4. Allergy
        4.7.5. Others
   4.8. Market Size (US$ Mn) Forecast By Disease Indication, 2017–2025
        4.8.1. Central Nervous System Diseases (CNS)
        4.8.2. Gastrointestinal (GI) Diseases
        4.8.3. Cardiovascular(CVS) Diseases
        4.8.4. Allergy
        4.8.5. Others
   4.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        4.9.1. Hospital Pharmacy
        4.9.2. Retail Pharmacy
        4.9.3. Drug Stores
        4.9.4. Online Pharmacy
   4.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        4.10.1. Hospital Pharmacy
        4.10.2. Retail Pharmacy
        4.10.3. Drug Stores
        4.10.4. Online Pharmacy
   4.11. Drivers and Restraints: Impact Analysis
   4.12. Market Attractiveness Analysis
        4.12.1. By Country
        4.12.2. By Drug Class
        4.12.3. By Disease Indication
        4.12.4. By Distribution Channel
   4.13. Key Representative Market Participants
   4.14. Market Presence (Intensity Map)

5. Latin America Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025
   5.1. Introduction
   5.2. Regional Market Dynamics
        5.2.1. Drivers
        5.2.2. Restraints
        5.2.3. Trends
   5.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        5.3.1. Brazil
        5.3.2. Mexico
        5.3.3. Rest of Latin America
   5.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        5.4.1. Brazil
        5.4.2. Mexico
        5.4.3. Rest of Latin America
   5.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        5.5.1. Anti-Psychotic
        5.5.2. Anti-Epileptic’s
        5.5.3. CNS Stimulants
        5.5.4. Anxiolytics
        5.5.5. Anti-Parkinson Ian Drugs
        5.5.6. Anti-Hypertensive
        5.5.7. NSAIDS
        5.5.8. Anti-Allergy Drugs
        5.5.9. Proton Pump Inhibitor
        5.5.10. Others
   5.6. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        5.6.1. Anti-Psychotic
        5.6.2. Anti-Epileptic’s
        5.6.3. CNS Stimulants
        5.6.4. Anxiolytics
        5.6.5. Anti-Parkinson Ian Drugs
        5.6.6. Anti-Hypertensive
        5.6.7. NSAIDS
        5.6.8. Anti-Allergy Drugs
        5.6.9. Proton Pump Inhibitor
        5.6.10. Others
   5.7. Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016
        5.7.1. Central Nervous System Diseases (CNS)
        5.7.2. Gastrointestinal (GI) Diseases
        5.7.3. Cardiovascular(CVS) Diseases
        5.7.4. Allergy
        5.7.5. Others
   5.8. Market Size (US$ Mn) Forecast By Disease Indication, 2017–2025
        5.8.1. Central Nervous System Diseases (CNS)
        5.8.2. Gastrointestinal (GI) Diseases
        5.8.3. Cardiovascular(CVS) Diseases
        5.8.4. Allergy
        5.8.5. Others
   5.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        5.9.1. Hospital Pharmacy
        5.9.2. Retail Pharmacy
        5.9.3. Drug Stores
        5.9.4. Online Pharmacy
   5.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        5.10.1. Hospital Pharmacy
        5.10.2. Retail Pharmacy
        5.10.3. Drug Stores
        5.10.4. Online Pharmacy
   5.11. Drivers and Restraints: Impact Analysis
   5.12. Market Attractiveness Analysis
        5.12.1. By Country
        5.12.2. By Drug Class
        5.12.3. By Disease Indication
        5.12.4. By Distribution Channel
   5.13. Key Representative Market Participants
   5.14. Market Presence (Intensity Map)

6. Europe Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025
   6.1. Introduction
   6.2. Regional Market Dynamics
        6.2.1. Drivers
        6.2.2. Restraints
        6.2.3. Trends
   6.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        6.3.1. Germany
        6.3.2. U.K.
        6.3.3. France
        6.3.4. Italy
        6.3.5. Spain
        6.3.6. Russia
        6.3.7. Rest of Europe
   6.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        6.4.1. Germany
        6.4.2. U.K.
        6.4.3. France
        6.4.4. Italy
        6.4.5. Spain
        6.4.6. Russia
        6.4.7. Rest of Europe
   6.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        6.5.1. Anti-Psychotic
        6.5.2. Anti-Epileptic’s
        6.5.3. CNS Stimulants
        6.5.4. Anxiolytics
        6.5.5. Anti-Parkinson Ian Drugs
        6.5.6. Anti-Hypertensive
        6.5.7. NSAIDS
        6.5.8. Anti-Allergy Drugs
        6.5.9. Proton Pump Inhibitor
        6.5.10. Others
   6.6. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        6.6.1. Anti-Psychotic
        6.6.2. Anti-Epileptic’s
        6.6.3. CNS Stimulants
        6.6.4. Anxiolytics
        6.6.5. Anti-Parkinson Ian Drugs
        6.6.6. Anti-Hypertensive
        6.6.7. NSAIDS
        6.6.8. Anti-Allergy Drugs
        6.6.9. Proton Pump Inhibitor
        6.6.10. Others
   6.7. Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016
        6.7.1. Central Nervous System Diseases (CNS)
        6.7.2. Gastrointestinal (GI) Diseases
        6.7.3. Cardiovascular(CVS) Diseases
        6.7.4. Allergy
        6.7.5. Others
   6.8. Market Size (US$ Mn) Forecast By Disease Indication, 2017–2025
        6.8.1. Central Nervous System Diseases (CNS)
        6.8.2. Gastrointestinal (GI) Diseases
        6.8.3. Cardiovascular(CVS) Diseases
        6.8.4. Allergy
        6.8.5. Others
   6.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        6.9.1. Hospital Pharmacy
        6.9.2. Retail Pharmacy
        6.9.3. Drug Stores
        6.9.4. Online Pharmacy
   6.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        6.10.1. Hospital Pharmacy
        6.10.2. Retail Pharmacy
        6.10.3. Drug Stores
        6.10.4. Online Pharmacy
   6.11. Drivers and Restraints: Impact Analysis
   6.12. Market Attractiveness Analysis
        6.12.1. By Country
        6.12.2. By Drug Class
        6.12.3. By Disease Indication
        6.12.4. By Distribution Channel
   6.13. Key Representative Market Participants
   6.14. Market Presence (Intensity Map)

7. Asia Pacific Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025
   7.1. Introduction
   7.2. Regional Market Dynamics
        7.2.1. Drivers
        7.2.2. Restraints
        7.2.3. Trends
   7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        7.3.1. Japan
        7.3.2. Australia and New Zealand
        7.3.3. China
        7.3.4. India
        7.3.5. Rest of Asia Pacific
   7.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        7.4.1. Japan
        7.4.2. Australia and New Zealand
        7.4.3. China
        7.4.4. India
        7.4.5. Rest of Asia Pacific
   7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        7.5.1. Anti-Psychotic
        7.5.2. Anti-Epileptic’s
        7.5.3. CNS Stimulants
        7.5.4. Anxiolytics
        7.5.5. Anti-Parkinson Ian Drugs
        7.5.6. Anti-Hypertensive
        7.5.7. NSAIDS
        7.5.8. Anti-Allergy Drugs
        7.5.9. Proton Pump Inhibitor
        7.5.10. Others
   7.6. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        7.6.1. Anti-Psychotic
        7.6.2. Anti-Epileptic’s
        7.6.3. CNS Stimulants
        7.6.4. Anxiolytics
        7.6.5. Anti-Parkinson Ian Drugs
        7.6.6. Anti-Hypertensive
        7.6.7. NSAIDS
        7.6.8. Anti-Allergy Drugs
        7.6.9. Proton Pump Inhibitor
        7.6.10. Others
   7.7. Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016
        7.7.1. Central Nervous System Diseases (CNS)
        7.7.2. Gastrointestinal (GI) Diseases
        7.7.3. Cardiovascular(CVS) Diseases
        7.7.4. Allergy
        7.7.5. Others
   7.8. Market Size (US$ Mn) Forecast By Disease Indication, 2017–2025
        7.8.1. Central Nervous System Diseases (CNS)
        7.8.2. Gastrointestinal (GI) Diseases
        7.8.3. Cardiovascular(CVS) Diseases
        7.8.4. Allergy
        7.8.5. Others
   7.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        7.9.1. Hospital Pharmacy
        7.9.2. Retail Pharmacy
        7.9.3. Drug Stores
        7.9.4. Online Pharmacy
   7.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        7.10.1. Hospital Pharmacy
        7.10.2. Retail Pharmacy
        7.10.3. Drug Stores
        7.10.4. Online Pharmacy
   7.11. Drivers and Restraints: Impact Analysis
   7.12. Market Attractiveness Analysis
        7.12.1. By Country
        7.12.2. By Drug Class
        7.12.3. By Disease Indication
        7.12.4. By Distribution Channel
   7.13. Key Representative Market Participants
   7.14. Market Presence (Intensity Map)

8. Middle East & Africa Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025
   8.1. Introduction
   8.2. Regional Market Dynamics
        8.2.1. Drivers
        8.2.2. Restraints
        8.2.3. Trends
   8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
        8.3.1. GCC Countries
        8.3.2. South Africa
        8.3.3. Rest of MEA
   8.4. Market Size (US$ Mn) Forecast By Country, 2017–2025
        8.4.1. GCC Countries
        8.4.2. South Africa
        8.4.3. Rest of MEA
   8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Class, 2012–2016
        8.5.1. Anti-Psychotic
        8.5.2. Anti-Epileptic’s
        8.5.3. CNS Stimulants
        8.5.4. Anxiolytics
        8.5.5. Anti-Parkinson Ian Drugs
        8.5.6. Anti-Hypertensive
        8.5.7. NSAIDS
        8.5.8. Anti-Allergy Drugs
        8.5.9. Proton Pump Inhibitor
        8.5.10. Others
   8.6. Market Size (US$ Mn) Forecast By Drug Class, 2017–2025
        8.6.1. Anti-Psychotic
        8.6.2. Anti-Epileptic’s
        8.6.3. CNS Stimulants
        8.6.4. Anxiolytics
        8.6.5. Anti-Parkinson Ian Drugs
        8.6.6. Anti-Hypertensive
        8.6.7. NSAIDS
        8.6.8. Anti-Allergy Drugs
        8.6.9. Proton Pump Inhibitor
        8.6.10. Others
   8.7. Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016
        8.7.1. Central Nervous System Diseases (CNS)
        8.7.2. Gastrointestinal (GI) Diseases
        8.7.3. Cardiovascular(CVS) Diseases
        8.7.4. Allergy
        8.7.5. Others
   8.8. Market Size (US$ Mn) Forecast By Disease Indication, 2017–2025
        8.8.1. Central Nervous System Diseases (CNS)
        8.8.2. Gastrointestinal (GI) Diseases
        8.8.3. Cardiovascular(CVS) Diseases
        8.8.4. Allergy
        8.8.5. Others
   8.9. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        8.9.1. Hospital Pharmacy
        8.9.2. Retail Pharmacy
        8.9.3. Drug Stores
        8.9.4. Online Pharmacy
   8.10. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        8.10.1. Hospital Pharmacy
        8.10.2. Retail Pharmacy
        8.10.3. Drug Stores
        8.10.4. Online Pharmacy
   8.11. Drivers and Restraints: Impact Analysis
   8.12. Market Attractiveness Analysis
        8.12.1. By Country
        8.12.2. By Drug Class
        8.12.3. By Disease Indication
        8.12.4. By Distribution Channel
   8.13. Key Representative Market Participants
   8.14. Market Presence (Intensity Map)

9. Competition Landscape
   9.1. Market Structure
   9.2. Market Share Analysis
   9.3. Competition Dashboard
   9.4. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
        9.4.1. Teva Pharmaceutical Industries Ltd.
        9.4.2. Novartis AG
        9.4.3. AstraZeneca
        9.4.4. Mylan N.V.
        9.4.5. Pfizer Inc.
        9.4.6. Johnson & Johnson Services, Inc.
        9.4.7. F. Hoffmann-La Roche Ltd.
        9.4.8. Merck & Co., Inc.
        9.4.9. Valeant
        9.4.10. GlaxoSmithKline plc.
        9.4.11. Sun Pharmaceutical Industries Ltd.
        9.4.12. Bayer AG
        9.4.13. Eli Lilly and Company
        9.4.14. Dr. Reddy’s Laboratories Ltd
        9.4.15. Takeda Pharmaceutical Company Limited
        9.4.16. Eisai Co., Ltd.
        9.4.17. Zydus Cadila
        9.4.18. NEOS Therapeutics, Inc.
        9.4.19. Glenmark
        9.4.20. Unichem Laboratories.

10. Global Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025, By Region
   10.1. Introduction/Key Findings
   10.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
        10.2.1. North America
        10.2.2. Latin America
        10.2.3. Europe
        10.2.4. Asia Pacific
        10.2.5. Middle East & Africa
   10.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
        10.3.1. North America
        10.3.2. Latin America
        10.3.3. Europe
        10.3.4. Asia Pacific
        10.3.5. Middle East & Africa
   10.4. Market Attractiveness Analysis By Region

11. Global Orally Disintegrating Tablets Analysis 2012–2016 and Forecast 2017–2025, By Drug Class
   11.1. Introduction/Key Findings
   11.2. Historical Market Size (US$ Mn) and Trend Analysis By Drug Class, 2012–2016
        11.2.1. Anti-Psychotic
        11.2.2. Anti-Epileptic’s
        11.2.3. CNS Stimulants
        11.2.4. Anxiolytics
        11.2.5. Anti-Parkinson Ian Drugs
        11.2.6. Anti-Hypertensive
        11.2.7. NSAIDS
        11.2.8. Anti-Allergy Drugs
        11.2.9. Proton Pump Inhibitor
        11.2.10. Others
   11.3. Market Size (US$ Mn) and Forecast By Drug Class, 2017–2025
        11.3.1. Anti-Psychotic
        11.3.2. Anti-Epileptic’s
        11.3.3. CNS Stimulants
        11.3.4. Anxiolytics
        11.3.5. Anti-Parkinson Ian Drugs
        11.3.6. Anti-Hypertensive
        11.3.7. NSAIDS
        11.3.8. Anti-Allergy Drugs
        11.3.9. Proton Pump Inhibitor
        11.3.10. Others
   11.4. Market Attractiveness Analysis By Drug Class

12. Global Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025, By Disease Indication
   12.1. Introduction/Key Findings
   12.2. Historical Market Size (US$ Mn) Trend Analysis By Disease Indication, 2012–2016
        12.2.1. Central Nervous System Diseases (CNS)
        12.2.2. Gastrointestinal (GI) Diseases
        12.2.3. Cardiovascular(CVS) Diseases
        12.2.4. Allergy
        12.2.5. Others
   12.3. Market Size (US$ Mn) Forecast By Disease Indication, 2017–2025
        12.3.1. Central Nervous System Diseases (CNS)
        12.3.2. Gastrointestinal (GI) Diseases
        12.3.3. Cardiovascular(CVS) Diseases
        12.3.4. Allergy
        12.3.5. Others
   12.4. Market Attractiveness Analysis By Disease Indication

13. Global Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025, By Distribution Channel
   13.1. Introduction/Key Findings
   13.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2012–2016
        13.2.1. Hospital Pharmacy
        13.2.2. Retail Pharmacy
        13.2.3. Drug Stores
        13.2.4. Online Pharmacy
   13.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2017–2025
        13.3.1. Hospital Pharmacy
        13.3.2. Retail Pharmacy
        13.3.3. Drug Stores
        13.3.4. Online Pharmacy
   13.4. Market Attractiveness Analysis By Distribution Channel

14. Global Orally Disintegrating Tablets Market Analysis 2012–2016 and Forecast 2017–2025
   14.1.Market Size and Y-o-Y Growth
   14.2.Absolute $ Opportunity


List of Table

Table 1: North America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 2: North America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
Table 3: North America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication 
Table 4: North America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 5: Latin America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 6: Latin America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
Table 7: Latin America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication 
Table 8: Latin America Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 9: Europe Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 10: Europe Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
Table 11: Europe Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication 
Table 12: Europe Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 13: Asia-Pacific Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 14: Asia-Pacific Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
Table 15: Asia-Pacific Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication 
Table 16: Asia Pacific Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 17: MEA Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 18: MEA Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
Table 19: MEA Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication 
Table 20: MEA Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Distribution Channel
Table 21: Global Orally Disintegrating Tablets Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region, 
Table 22: Global Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Drug Class
Table 23: Global Orally Disintegrating Tablets Market Size Analysis (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Disease Indication 
Table 24: Global Orally Disintegrating Tablets Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Distribution Channel,


List of Figure

Figure 1: Global Orally Disintegrating Tablets Market Split By Drug Class (2017E)
Figure 2: Global Orally Disintegrating Tablets Market Split By Disease Indication (2017E)
Figure 3: Global Orally Disintegrating Tablets Market Split By Distribution Channel (2017E)
Figure 4: Global Orally Disintegrating Tablets Market Split By Region (2017E)
Figure 5: North America Orally Disintegrating Tablets Market Split By Drug Class (2017E)
Figure 6: North America Orally Disintegrating Tablets Market Split By Disease Indication (2017E)
Figure 7: North America Orally Disintegrating Tablets Market Split By Distribution Channel (2017E)
Figure 8: North America Orally Disintegrating Tablets Market Split By Country (2017E)
Figure 9: North America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 10: North America Orally Disintegrating Tablets Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 11: U.S. Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 12: U.S. Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 13: Canada Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 14: Canada Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 15: North America Orally Disintegrating Tablets Market Attractiveness Analysis, By Country
Figure 16: North America Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class
Figure 17: North America Orally Disintegrating Tablets Market Attractiveness Analysis, By Disease Indication
Figure 18: North America Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel
Figure 19: Latin America Orally Disintegrating Tablets Market Split By Drug Class (2017E)
Figure 20: Latin America Orally Disintegrating Tablets Market Split By Disease Indication (2017E)
Figure 21: Latin America Orally Disintegrating Tablets Market Split By Distribution Channel (2017E)
Figure 22: Latin America Orally Disintegrating Tablets Market Split By Region (2017E)
Figure 23: Latin America Orally Disintegrating Tablets Market Size Analysis, 2012–2016
Figure 24: Latin America Orally Disintegrating Tablets Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 25: Brazil Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 26: Brazil Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 27: Mexico Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 28: Mexico Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 29: Rest of Latin America Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 30: Rest of Latin America Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 31: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis, By Country 
Figure 32: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Type
Figure 33: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis, By Disease Indication 
Figure 34: Latin America Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel 
Figure 35: Europe Orally Disintegrating Tablets Market Split By Drug Class (2017E)
Figure 36: Europe Orally Disintegrating Tablets Market Split By Disease Indication (2017E)
Figure 37: Europe Orally Disintegrating Tablets Market Split By Distribution Channel (2017E)
Figure 38: Europe Orally Disintegrating Tablets Market Split By Country (2017E)
Figure 39: Europe Orally Disintegrating Tablets Market Size Analysis, 2012–2016
Figure 40: Europe Orally Disintegrating Tablets Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 41: Germany Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 42: Germany Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 43: France Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 44: France Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 45: U.K Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 46: U.K Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 47: Italy Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 48: Italy Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 49: Spain Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 50: Spain Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 51: Russia Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 52: Russia Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 53: Rest of Europe Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 54: Rest of Europe Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 55: Europe Orally Disintegrating Tablets Market Attractiveness Analysis, By Country
Figure 56: Europe Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Type
Figure 57: Europe Orally Disintegrating Tablets Market Attractiveness Analysis, By Disease Indication 
Figure 58: Europe Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel 
Figure 59: Asia-Pacific Orally Disintegrating Tablets Market Split By Drug Class (2017)
Figure 60: Asia-Pacific Orally Disintegrating Tablets Market Split By Disease Indication (2017)
Figure 61: Asia-Pacific Orally Disintegrating Tablets Market Split By Distribution Channel (2017)
Figure 62: Asia-Pacific Orally Disintegrating Tablets Market Split By Region (2017)
Figure 63: Asia-Pacific Orally Disintegrating Tablets Market Size Analysis, 2012–2016
Figure 64: Asia-Pacific Orally Disintegrating Tablets Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 65: Japan Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 66: Japan Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 67: Australia & New Zealand Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 68: Australia & New Zealand Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 69: China Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 70: China Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 71: India Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 72: India Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 73: Rest of APAC Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 74: Rest of APAC Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 75: Asia Pacific Orally Disintegrating Tablets Market Attractiveness Analysis, By Country 
Figure 76: Asia Pacific Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Class
Figure 77: Asia Pacific Orally Disintegrating Tablets Market Attractiveness Analysis, By Disease Indication
Figure 78: Asia Pacific Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel 
Figure 79: MEA Orally Disintegrating Tablets Market Split By Drug Class (2017E)
Figure 80: MEA Orally Disintegrating Tablets Market Split By Disease Indication (2017E)
Figure 81: MEA Orally Disintegrating Tablets Market Split By Distribution Channel (2017E)
Figure 82: MEA Orally Disintegrating Tablets Market Split By Region (2017E)
Figure 83: MEA Orally Disintegrating Tablets Market Size Analysis, 2012–2016
Figure 84: MEA Orally Disintegrating Tablets Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 85: GCC Countries Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 86: GCC Countries Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 87: South Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 88: South Africa Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 89: Rest of Middle East & Africa Orally Disintegrating Tablets Market Size (US$ Mn) Analysis, 2012–2016
Figure 90: Rest of Middle East & Africa Orally Disintegrating Tablets Market Value (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 91: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Country
Figure 92: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Drug Type
Figure 93: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Disease Indication
Figure 94: MEA Orally Disintegrating Tablets Market Attractiveness Analysis, By Distribution Channel
Figure 95: Global Orally Disintegrating Tablet Company Market Share Analysis, 2016
Figure 96: Global Orally Disintegrating Tablets Market Share Analysis (%) By Region, 2017 & 2025
Figure 97: Global Orally Disintegrating Tablets Market Y-o-Y Growth (%) By Region, 2016–2025
Figure 98: Global Orally Disintegrating Tablets Market Attractiveness Analysis By Region, 2017–2025
Figure 99: Global Orally Disintegrating Tablets Market Share Analysis (%) By Drug Class, 2017 & 2025
Figure 100: Global Orally Disintegrating Tablets Market Y-o-Y Growth (%) By Drug Class, 2016–2025
Figure 101: Global Orally Disintegrating Tablets Market Attractiveness Analysis By Drug Class, 2017–2025
Figure 102: Global Orally Disintegrating Tablets Market Share Analysis (%) By Drug Indication, 2017 & 2025
Figure 103: Global Orally Disintegrating Tablets Market Y-o-Y Growth (%) By Drug Indication, 2016–2025
Figure 104: Global Orally Disintegrating Tablets Market Attractiveness Analysis By Drug Indication, 2017–2025
Figure 105: Global Orally Disintegrating Tablets Market Share Analysis (%) By Distribution Channel, 2017 & 2025
Figure 106: Global Orally Disintegrating Tablets Market Y-o-Y Growth (%) By Distribution Channel, 2016–2025
Figure 107: Global Orally Disintegrating Tablets Market Attractiveness Analysis By Distribution Channel, 2017–2025
Figure 108: Global Orally Disintegrating Tablets Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 109: Global Orally Disintegrating Tablets Market Value (US$ Mn), 2012–2016
Figure 110: Global Orally Disintegrating Tablets Market Absolute $ Opportunity (US$ Mn), 2016–2025